A HEMODIALYSIS PATIENT WITH MYELODYSPLASTIC SYNDROME TREATED WITH AZACITIDINE

被引：0
|
作者：
Hiraga, Junji [1 ]
Nishimura, Hayato [2 ]
Kurata, Hisashi [2 ]
Kagami, Yoshitoyo [1 ]
机构：
[1] Toyota Kosei Hosp, Dept Hematol, Toyota, Japan
[2] Toyota Kosei Hosp, Dept Nephrol, Toyota, Japan
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-21-3
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidine
    Itzykson, R.
    Thepot, S.
    Eclache, V.
    Quesnel, B.
    Dreyfus, F.
    Beyne-Rauzy, O.
    Turlure, P.
    Vey, N.
    Recher, C.
    Boehrer, S.
    Gardin, C.
    Ades, L.
    Fenaux, P.
    LEUKEMIA, 2011, 25 (07) : 1207 - 1209
  • [22] Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidine
    R Itzykson
    S Thépot
    V Eclache
    B Quesnel
    F Dreyfus
    O Beyne-Rauzy
    P Turlure
    N Vey
    C Recher
    S Boehrer
    C Gardin
    L Adès
    P Fenaux
    Leukemia, 2011, 25 : 1207 - 1209
  • [23] Oral Azacitidine in Patients With Myelodysplastic Syndrome
    Shibusawa, Motoharu
    Kidoguchi, Keisuke
    Tanimoto, Tetsuya
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (27) : 3091 - +
  • [24] Azacitidine-induced pyoderma gangrenosum at injection sites in a patient with myelodysplastic syndrome
    Roy, C.
    Adam, J. P.
    Morin, F.
    Lemieux-Blanchard, E.
    Doucet, S.
    Friedmann, D.
    Belisle, A.
    Charpentier, D.
    CURRENT ONCOLOGY, 2018, 25 (01) : E103 - E105
  • [25] Recurrent arthritis as an unexpected side effect associated with azacitidine in a patient with myelodysplastic syndrome
    Iltar, Utku
    Alhan, Fadime Nurcan
    Vural, Ece
    Atas, Unal
    Sozel, Hasan
    Dogan, Omer
    Boduroglu, Ahmet
    Yucel, Orhan Kemal
    Salim, Ozan
    Undar, Levent
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (02) : 500 - 503
  • [26] Prolonged gastric mucosal haemorrhage following azacitidine administration in a patient with myelodysplastic syndrome
    Kitamura, Hiroaki
    Miyahara, Koichi
    Kubota, Yasushi
    Tomimasu, Rika
    Kimura, Shinya
    Miyahara, Masaharu
    EJHAEM, 2021, 2 (03): : 653 - 654
  • [27] Azacitidine-induced pyoderma gangrenosum at injection sites in a patient with myelodysplastic syndrome
    Morin, Frederique
    Friedmann, Dominique
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB54 - AB54
  • [28] Azacitidine in an AML patient under hemodialysis
    Gueluek, S.
    Galle, J.
    Kalb, K.
    Heil, G.
    ONKOLOGIE, 2012, 35 : 123 - 123
  • [29] Impact of Nagasaki Atomic Bomb Exposure on Myelodysplastic Syndrome Patients Who Are Treated with Azacitidine
    Jo, Tatsuro
    Horio, Kensuke
    Shigematsu, Kazuto
    ANTICANCER RESEARCH, 2015, 35 (05) : 2929 - 2933
  • [30] Relationship between p53 expression and prognosis of myelodysplastic syndrome treated with azacitidine
    Oka, Satoko
    Ono, Kazuo
    Nohgawa, Masaharu
    JOURNAL OF HEMATOPATHOLOGY, 2020, 13 (04) : 213 - 219
12345